Table S1 from Comparative Cistromics Reveals Genomic Cross-talk between FOXA1 and ERα in Tamoxifen-Associated Endometrial Carcinomas Article Swipe
Marjolein Droog
,
Ekaterina Nevedomskaya
,
Yongsoo Kim
,
Tesa Severson
,
Koen D. Flach
,
Mark Opdam
,
Karianne Schuurman
,
Patrycja Gradowska
,
Michael Hauptmann
,
Gwen Dackus
,
Harry Hollema
,
Marian J.E. Mourits
,
Petra M. Nederlof
,
Hester van Boven
,
Sabine C. Linn
,
Lodewyk F.A. Wessels
,
Flora E. van Leeuwen
,
Wilbert Zwart
·
YOU?
·
· 2023
· Open Access
·
· DOI: https://doi.org/10.1158/0008-5472.22408713.v1
YOU?
·
· 2023
· Open Access
·
· DOI: https://doi.org/10.1158/0008-5472.22408713.v1
Clinicopathological parameters of patient samples in the TAMARISK-study. MC-UC = interval between breast cancer and endometrial cancer.
Related Topics
Concepts
Tamoxifen
Endometrial cancer
Oncology
Internal medicine
FOXA1
Medicine
Breast cancer
Carcinoma
HER2 negative
Gynecology
Cancer
Metastatic breast cancer
Metadata
- Type
- preprint
- Language
- en
- Landing Page
- https://doi.org/10.1158/0008-5472.22408713.v1
- OA Status
- gold
- Related Works
- 10
- OpenAlex ID
- https://openalex.org/W4361850147
All OpenAlex metadata
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W4361850147Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.1158/0008-5472.22408713.v1Digital Object Identifier
- Title
-
Table S1 from Comparative Cistromics Reveals Genomic Cross-talk between FOXA1 and ERα in Tamoxifen-Associated Endometrial CarcinomasWork title
- Type
-
preprintOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2023Year of publication
- Publication date
-
2023-03-30Full publication date if available
- Authors
-
Marjolein Droog, Ekaterina Nevedomskaya, Yongsoo Kim, Tesa Severson, Koen D. Flach, Mark Opdam, Karianne Schuurman, Patrycja Gradowska, Michael Hauptmann, Gwen Dackus, Harry Hollema, Marian J.E. Mourits, Petra M. Nederlof, Hester van Boven, Sabine C. Linn, Lodewyk F.A. Wessels, Flora E. van Leeuwen, Wilbert ZwartList of authors in order
- Landing page
-
https://doi.org/10.1158/0008-5472.22408713.v1Publisher landing page
- Open access
-
YesWhether a free full text is available
- OA status
-
goldOpen access status per OpenAlex
- OA URL
-
https://doi.org/10.1158/0008-5472.22408713.v1Direct OA link when available
- Concepts
-
Tamoxifen, Endometrial cancer, Oncology, Internal medicine, FOXA1, Medicine, Breast cancer, Carcinoma, HER2 negative, Gynecology, Cancer, Metastatic breast cancerTop concepts (fields/topics) attached by OpenAlex
- Cited by
-
0Total citation count in OpenAlex
- Related works (count)
-
10Other works algorithmically related by OpenAlex
Full payload
| id | https://openalex.org/W4361850147 |
|---|---|
| doi | https://doi.org/10.1158/0008-5472.22408713.v1 |
| ids.doi | https://doi.org/10.1158/0008-5472.22408713.v1 |
| ids.openalex | https://openalex.org/W4361850147 |
| fwci | 0.0 |
| type | preprint |
| title | Table S1 from Comparative Cistromics Reveals Genomic Cross-talk between FOXA1 and ERα in Tamoxifen-Associated Endometrial Carcinomas |
| biblio.issue | |
| biblio.volume | |
| biblio.last_page | |
| biblio.first_page | |
| topics[0].id | https://openalex.org/T10756 |
| topics[0].field.id | https://openalex.org/fields/13 |
| topics[0].field.display_name | Biochemistry, Genetics and Molecular Biology |
| topics[0].score | 0.8434000015258789 |
| topics[0].domain.id | https://openalex.org/domains/1 |
| topics[0].domain.display_name | Life Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/1311 |
| topics[0].subfield.display_name | Genetics |
| topics[0].display_name | Estrogen and related hormone effects |
| topics[1].id | https://openalex.org/T10668 |
| topics[1].field.id | https://openalex.org/fields/27 |
| topics[1].field.display_name | Medicine |
| topics[1].score | 0.8379999995231628 |
| topics[1].domain.id | https://openalex.org/domains/4 |
| topics[1].domain.display_name | Health Sciences |
| topics[1].subfield.id | https://openalex.org/subfields/2729 |
| topics[1].subfield.display_name | Obstetrics and Gynecology |
| topics[1].display_name | Endometrial and Cervical Cancer Treatments |
| topics[2].id | https://openalex.org/T11765 |
| topics[2].field.id | https://openalex.org/fields/13 |
| topics[2].field.display_name | Biochemistry, Genetics and Molecular Biology |
| topics[2].score | 0.7605999708175659 |
| topics[2].domain.id | https://openalex.org/domains/1 |
| topics[2].domain.display_name | Life Sciences |
| topics[2].subfield.id | https://openalex.org/subfields/1312 |
| topics[2].subfield.display_name | Molecular Biology |
| topics[2].display_name | Circular RNAs in diseases |
| is_xpac | False |
| apc_list | |
| apc_paid | |
| concepts[0].id | https://openalex.org/C2777176818 |
| concepts[0].level | 4 |
| concepts[0].score | 0.7568819522857666 |
| concepts[0].wikidata | https://www.wikidata.org/wiki/Q412178 |
| concepts[0].display_name | Tamoxifen |
| concepts[1].id | https://openalex.org/C2777088508 |
| concepts[1].level | 3 |
| concepts[1].score | 0.6568536758422852 |
| concepts[1].wikidata | https://www.wikidata.org/wiki/Q944777 |
| concepts[1].display_name | Endometrial cancer |
| concepts[2].id | https://openalex.org/C143998085 |
| concepts[2].level | 1 |
| concepts[2].score | 0.5734785199165344 |
| concepts[2].wikidata | https://www.wikidata.org/wiki/Q162555 |
| concepts[2].display_name | Oncology |
| concepts[3].id | https://openalex.org/C126322002 |
| concepts[3].level | 1 |
| concepts[3].score | 0.5580252408981323 |
| concepts[3].wikidata | https://www.wikidata.org/wiki/Q11180 |
| concepts[3].display_name | Internal medicine |
| concepts[4].id | https://openalex.org/C154456304 |
| concepts[4].level | 4 |
| concepts[4].score | 0.5047038793563843 |
| concepts[4].wikidata | https://www.wikidata.org/wiki/Q18027046 |
| concepts[4].display_name | FOXA1 |
| concepts[5].id | https://openalex.org/C71924100 |
| concepts[5].level | 0 |
| concepts[5].score | 0.4908943772315979 |
| concepts[5].wikidata | https://www.wikidata.org/wiki/Q11190 |
| concepts[5].display_name | Medicine |
| concepts[6].id | https://openalex.org/C530470458 |
| concepts[6].level | 3 |
| concepts[6].score | 0.48964816331863403 |
| concepts[6].wikidata | https://www.wikidata.org/wiki/Q128581 |
| concepts[6].display_name | Breast cancer |
| concepts[7].id | https://openalex.org/C2777546739 |
| concepts[7].level | 2 |
| concepts[7].score | 0.4433935284614563 |
| concepts[7].wikidata | https://www.wikidata.org/wiki/Q33525 |
| concepts[7].display_name | Carcinoma |
| concepts[8].id | https://openalex.org/C2910363380 |
| concepts[8].level | 5 |
| concepts[8].score | 0.4255063831806183 |
| concepts[8].wikidata | https://www.wikidata.org/wiki/Q128581 |
| concepts[8].display_name | HER2 negative |
| concepts[9].id | https://openalex.org/C29456083 |
| concepts[9].level | 1 |
| concepts[9].score | 0.35171371698379517 |
| concepts[9].wikidata | https://www.wikidata.org/wiki/Q1221899 |
| concepts[9].display_name | Gynecology |
| concepts[10].id | https://openalex.org/C121608353 |
| concepts[10].level | 2 |
| concepts[10].score | 0.3228352963924408 |
| concepts[10].wikidata | https://www.wikidata.org/wiki/Q12078 |
| concepts[10].display_name | Cancer |
| concepts[11].id | https://openalex.org/C2775930923 |
| concepts[11].level | 4 |
| concepts[11].score | 0.0637056827545166 |
| concepts[11].wikidata | https://www.wikidata.org/wiki/Q12859063 |
| concepts[11].display_name | Metastatic breast cancer |
| keywords[0].id | https://openalex.org/keywords/tamoxifen |
| keywords[0].score | 0.7568819522857666 |
| keywords[0].display_name | Tamoxifen |
| keywords[1].id | https://openalex.org/keywords/endometrial-cancer |
| keywords[1].score | 0.6568536758422852 |
| keywords[1].display_name | Endometrial cancer |
| keywords[2].id | https://openalex.org/keywords/oncology |
| keywords[2].score | 0.5734785199165344 |
| keywords[2].display_name | Oncology |
| keywords[3].id | https://openalex.org/keywords/internal-medicine |
| keywords[3].score | 0.5580252408981323 |
| keywords[3].display_name | Internal medicine |
| keywords[4].id | https://openalex.org/keywords/foxa1 |
| keywords[4].score | 0.5047038793563843 |
| keywords[4].display_name | FOXA1 |
| keywords[5].id | https://openalex.org/keywords/medicine |
| keywords[5].score | 0.4908943772315979 |
| keywords[5].display_name | Medicine |
| keywords[6].id | https://openalex.org/keywords/breast-cancer |
| keywords[6].score | 0.48964816331863403 |
| keywords[6].display_name | Breast cancer |
| keywords[7].id | https://openalex.org/keywords/carcinoma |
| keywords[7].score | 0.4433935284614563 |
| keywords[7].display_name | Carcinoma |
| keywords[8].id | https://openalex.org/keywords/her2-negative |
| keywords[8].score | 0.4255063831806183 |
| keywords[8].display_name | HER2 negative |
| keywords[9].id | https://openalex.org/keywords/gynecology |
| keywords[9].score | 0.35171371698379517 |
| keywords[9].display_name | Gynecology |
| keywords[10].id | https://openalex.org/keywords/cancer |
| keywords[10].score | 0.3228352963924408 |
| keywords[10].display_name | Cancer |
| keywords[11].id | https://openalex.org/keywords/metastatic-breast-cancer |
| keywords[11].score | 0.0637056827545166 |
| keywords[11].display_name | Metastatic breast cancer |
| language | en |
| locations[0].id | doi:10.1158/0008-5472.22408713.v1 |
| locations[0].is_oa | True |
| locations[0].source | |
| locations[0].license | cc-by |
| locations[0].pdf_url | |
| locations[0].version | acceptedVersion |
| locations[0].raw_type | posted-content |
| locations[0].license_id | https://openalex.org/licenses/cc-by |
| locations[0].is_accepted | True |
| locations[0].is_published | False |
| locations[0].raw_source_name | |
| locations[0].landing_page_url | https://doi.org/10.1158/0008-5472.22408713.v1 |
| locations[1].id | pmh:oai:figshare.com:article/22408713 |
| locations[1].is_oa | True |
| locations[1].source.id | https://openalex.org/S4306400572 |
| locations[1].source.issn | |
| locations[1].source.type | repository |
| locations[1].source.is_oa | False |
| locations[1].source.issn_l | |
| locations[1].source.is_core | False |
| locations[1].source.is_in_doaj | False |
| locations[1].source.display_name | OPAL (Open@LaTrobe) (La Trobe University) |
| locations[1].source.host_organization | https://openalex.org/I196829312 |
| locations[1].source.host_organization_name | La Trobe University |
| locations[1].source.host_organization_lineage | https://openalex.org/I196829312 |
| locations[1].license | cc-by |
| locations[1].pdf_url | |
| locations[1].version | submittedVersion |
| locations[1].raw_type | Text |
| locations[1].license_id | https://openalex.org/licenses/cc-by |
| locations[1].is_accepted | False |
| locations[1].is_published | False |
| locations[1].raw_source_name | |
| locations[1].landing_page_url | https://figshare.com/articles/journal_contribution/Table_S1_from_Comparative_Cistromics_Reveals_Genomic_Cross-talk_between_FOXA1_and_ER_in_Tamoxifen-Associated_Endometrial_Carcinomas/22408713 |
| indexed_in | crossref |
| authorships[0].author.id | https://openalex.org/A5037110669 |
| authorships[0].author.orcid | |
| authorships[0].author.display_name | Marjolein Droog |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | Marjolein Droog |
| authorships[0].is_corresponding | False |
| authorships[1].author.id | https://openalex.org/A5029670475 |
| authorships[1].author.orcid | |
| authorships[1].author.display_name | Ekaterina Nevedomskaya |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | Ekaterina Nevedomskaya |
| authorships[1].is_corresponding | False |
| authorships[2].author.id | https://openalex.org/A5023076355 |
| authorships[2].author.orcid | https://orcid.org/0000-0002-4277-0279 |
| authorships[2].author.display_name | Yongsoo Kim |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | Yongsoo Kim |
| authorships[2].is_corresponding | False |
| authorships[3].author.id | https://openalex.org/A5011590978 |
| authorships[3].author.orcid | https://orcid.org/0000-0002-7568-4705 |
| authorships[3].author.display_name | Tesa Severson |
| authorships[3].author_position | middle |
| authorships[3].raw_author_name | Tesa Severson |
| authorships[3].is_corresponding | False |
| authorships[4].author.id | https://openalex.org/A5064118435 |
| authorships[4].author.orcid | |
| authorships[4].author.display_name | Koen D. Flach |
| authorships[4].author_position | middle |
| authorships[4].raw_author_name | Koen D. Flach |
| authorships[4].is_corresponding | False |
| authorships[5].author.id | https://openalex.org/A5009334933 |
| authorships[5].author.orcid | https://orcid.org/0000-0001-5832-6386 |
| authorships[5].author.display_name | Mark Opdam |
| authorships[5].author_position | middle |
| authorships[5].raw_author_name | Mark Opdam |
| authorships[5].is_corresponding | False |
| authorships[6].author.id | https://openalex.org/A5007762420 |
| authorships[6].author.orcid | https://orcid.org/0000-0002-9278-0571 |
| authorships[6].author.display_name | Karianne Schuurman |
| authorships[6].author_position | middle |
| authorships[6].raw_author_name | Karianne Schuurman |
| authorships[6].is_corresponding | False |
| authorships[7].author.id | https://openalex.org/A5031409310 |
| authorships[7].author.orcid | https://orcid.org/0000-0002-4620-9163 |
| authorships[7].author.display_name | Patrycja Gradowska |
| authorships[7].author_position | middle |
| authorships[7].raw_author_name | Patrycja Gradowska |
| authorships[7].is_corresponding | False |
| authorships[8].author.id | https://openalex.org/A5041206659 |
| authorships[8].author.orcid | https://orcid.org/0000-0001-8539-0148 |
| authorships[8].author.display_name | Michael Hauptmann |
| authorships[8].author_position | middle |
| authorships[8].raw_author_name | Michael Hauptmann |
| authorships[8].is_corresponding | False |
| authorships[9].author.id | https://openalex.org/A5002570170 |
| authorships[9].author.orcid | https://orcid.org/0000-0002-5873-4926 |
| authorships[9].author.display_name | Gwen Dackus |
| authorships[9].author_position | middle |
| authorships[9].raw_author_name | Gwen Dackus |
| authorships[9].is_corresponding | False |
| authorships[10].author.id | https://openalex.org/A5009928901 |
| authorships[10].author.orcid | |
| authorships[10].author.display_name | Harry Hollema |
| authorships[10].author_position | middle |
| authorships[10].raw_author_name | Harry Hollema |
| authorships[10].is_corresponding | False |
| authorships[11].author.id | https://openalex.org/A5003474947 |
| authorships[11].author.orcid | https://orcid.org/0000-0003-2385-2639 |
| authorships[11].author.display_name | Marian J.E. Mourits |
| authorships[11].author_position | middle |
| authorships[11].raw_author_name | Marian J. Mourits |
| authorships[11].is_corresponding | False |
| authorships[12].author.id | https://openalex.org/A5079501701 |
| authorships[12].author.orcid | https://orcid.org/0000-0002-2358-9765 |
| authorships[12].author.display_name | Petra M. Nederlof |
| authorships[12].author_position | middle |
| authorships[12].raw_author_name | Petra Nederlof |
| authorships[12].is_corresponding | False |
| authorships[13].author.id | https://openalex.org/A5003942850 |
| authorships[13].author.orcid | |
| authorships[13].author.display_name | Hester van Boven |
| authorships[13].author_position | middle |
| authorships[13].raw_author_name | Hester van Boven |
| authorships[13].is_corresponding | False |
| authorships[14].author.id | https://openalex.org/A5063917865 |
| authorships[14].author.orcid | https://orcid.org/0000-0001-5541-0347 |
| authorships[14].author.display_name | Sabine C. Linn |
| authorships[14].author_position | middle |
| authorships[14].raw_author_name | Sabine C. Linn |
| authorships[14].is_corresponding | False |
| authorships[15].author.id | https://openalex.org/A5020129085 |
| authorships[15].author.orcid | https://orcid.org/0000-0002-1656-6995 |
| authorships[15].author.display_name | Lodewyk F.A. Wessels |
| authorships[15].author_position | middle |
| authorships[15].raw_author_name | Lodewyk Wessels |
| authorships[15].is_corresponding | False |
| authorships[16].author.id | https://openalex.org/A5030601121 |
| authorships[16].author.orcid | https://orcid.org/0000-0002-5871-1484 |
| authorships[16].author.display_name | Flora E. van Leeuwen |
| authorships[16].author_position | middle |
| authorships[16].raw_author_name | Flora E. van Leeuwen |
| authorships[16].is_corresponding | False |
| authorships[17].author.id | https://openalex.org/A5006708192 |
| authorships[17].author.orcid | https://orcid.org/0000-0002-9823-7289 |
| authorships[17].author.display_name | Wilbert Zwart |
| authorships[17].author_position | last |
| authorships[17].raw_author_name | Wilbert Zwart |
| authorships[17].is_corresponding | False |
| has_content.pdf | False |
| has_content.grobid_xml | False |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://doi.org/10.1158/0008-5472.22408713.v1 |
| open_access.oa_status | gold |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-10-10T00:00:00 |
| display_name | Table S1 from Comparative Cistromics Reveals Genomic Cross-talk between FOXA1 and ERα in Tamoxifen-Associated Endometrial Carcinomas |
| has_fulltext | False |
| is_retracted | False |
| updated_date | 2025-11-06T03:46:38.306776 |
| primary_topic.id | https://openalex.org/T10756 |
| primary_topic.field.id | https://openalex.org/fields/13 |
| primary_topic.field.display_name | Biochemistry, Genetics and Molecular Biology |
| primary_topic.score | 0.8434000015258789 |
| primary_topic.domain.id | https://openalex.org/domains/1 |
| primary_topic.domain.display_name | Life Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/1311 |
| primary_topic.subfield.display_name | Genetics |
| primary_topic.display_name | Estrogen and related hormone effects |
| related_works | https://openalex.org/W1981377089, https://openalex.org/W3177716708, https://openalex.org/W2075663330, https://openalex.org/W2529485187, https://openalex.org/W2002262418, https://openalex.org/W3157145723, https://openalex.org/W2314925876, https://openalex.org/W2152485630, https://openalex.org/W2280464122, https://openalex.org/W1842070729 |
| cited_by_count | 0 |
| locations_count | 2 |
| best_oa_location.id | doi:10.1158/0008-5472.22408713.v1 |
| best_oa_location.is_oa | True |
| best_oa_location.source | |
| best_oa_location.license | cc-by |
| best_oa_location.pdf_url | |
| best_oa_location.version | acceptedVersion |
| best_oa_location.raw_type | posted-content |
| best_oa_location.license_id | https://openalex.org/licenses/cc-by |
| best_oa_location.is_accepted | True |
| best_oa_location.is_published | False |
| best_oa_location.raw_source_name | |
| best_oa_location.landing_page_url | https://doi.org/10.1158/0008-5472.22408713.v1 |
| primary_location.id | doi:10.1158/0008-5472.22408713.v1 |
| primary_location.is_oa | True |
| primary_location.source | |
| primary_location.license | cc-by |
| primary_location.pdf_url | |
| primary_location.version | acceptedVersion |
| primary_location.raw_type | posted-content |
| primary_location.license_id | https://openalex.org/licenses/cc-by |
| primary_location.is_accepted | True |
| primary_location.is_published | False |
| primary_location.raw_source_name | |
| primary_location.landing_page_url | https://doi.org/10.1158/0008-5472.22408713.v1 |
| publication_date | 2023-03-30 |
| publication_year | 2023 |
| referenced_works_count | 0 |
| abstract_inverted_index.= | 9 |
| abstract_inverted_index.in | 5 |
| abstract_inverted_index.of | 2 |
| abstract_inverted_index.and | 14 |
| abstract_inverted_index.the | 6 |
| abstract_inverted_index.MC-UC | 8 |
| abstract_inverted_index.breast | 12 |
| abstract_inverted_index.cancer | 13 |
| abstract_inverted_index.between | 11 |
| abstract_inverted_index.patient | 3 |
| abstract_inverted_index.samples | 4 |
| abstract_inverted_index.interval | 10 |
| abstract_inverted_index.parameters | 1 |
| abstract_inverted_index.endometrial | 15 |
| abstract_inverted_index.TAMARISK-study. | 7 |
| abstract_inverted_index.cancer.</p> | 16 |
| abstract_inverted_index.<p>Clinicopathological | 0 |
| cited_by_percentile_year | |
| countries_distinct_count | 0 |
| institutions_distinct_count | 18 |
| sustainable_development_goals[0].id | https://metadata.un.org/sdg/3 |
| sustainable_development_goals[0].score | 0.8100000023841858 |
| sustainable_development_goals[0].display_name | Good health and well-being |
| citation_normalized_percentile.value | 0.06891446 |
| citation_normalized_percentile.is_in_top_1_percent | False |
| citation_normalized_percentile.is_in_top_10_percent | False |